Global Pharma Cloud Services Market Analysis and Industry Forecast 2035
According to Rohal Patil, who specializes in research and analysis of pharmaceuticals, cloud-based services, and healthcare IT, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the pharma cloud services market. The global pharma cloud services market size was estimated at USD 10.86 billion in 2025 and is predicted to increase from USD 12.47 billion in 2026 to approximately USD 43.18 billion by 2035, expanding at a CAGR of 14.8% from 2026 to 2035. His analysis highlights that the market’s growth can be attributed to the growing demand for remote data access, better data management, and the rising demand for pharmaceutical products. The research also examines the competitive strategies of key industry participants, including Lonza, Bristol Myers Squibb, Daiichi Sankyo, ImmunoGen, etc, shaping the future of the market.
Last Updated : 14 July 2026
Category: Healthcare IT
Insight Code: 6873
Format: PDF / PPT / Excel